EU actions

• € 3 million allocated for scientific studies on Schmallenberg virus. The studies will be co-financed by the Commission at 50% of eligible costs from 1 April 2012 - 31 December 2013 with maximum:
  • € 438.615 for Belgium;
  • € 595.883 for Germany;
  • € 146.590 for Spain;
  • € 589.380 for France;
  • € 124.120 for Italy;
  • € 639.342 for the Netherlands;
  • € 371.811 for the UK.
  • Read more
• Seminar on the management of Schmallenberg Virus, April 2012, Brussels. Non-EU countries shared their latest scientific data and risk management.
• Presentations

Related documents

• EFSA overview on intermediate technical report of the EU scientific studies on Schmallenberg virus – April 2013
• Analysis of the epidemiological data – EFSA report, November 2012
• Restriction to trade adopted in relation to Schmallenberg virus in the EU - EU communication at the 54th SPS Committee meeting, 10-11 July 2012, Geneva
• Analysis of epidemiological data & assessment of impact – EFSA report, June 2012
• Statement of EU Chief Veterinary Officers & the Commission, June 2012
• Analysis of epidemiological data - EFSA technical report, April 2012
• Statement by the Commission & countries, Feb. 2012
• Guidance document endorsed by the Standing Committee on the Food Chain and Animal Health (SCoFCAH), Feb. 2012
• EFSA preliminary analysis, Feb. 2012
• Commission note on the epidemiological situation, Jan. 2012
• SCoFCAH statement, Jan. 2012
• EU countries' presentations at SCoFCAH meetings